Transarterial chemoembolization of liver metastases in patients with uveal melanoma

European Journal of Radiology

Volumn 74, Issue 3, 2010, Pages

  Huppert, P E ^a   Fierlbeck, G ^b   Pereira, P ^b   Schanz, S ^b   Duda, S H ^b   Wietholtz, H ^a   Rozeik, C ^a   Claussen, C D ^b  

^a KLINIKUM DARMSTADT   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Chemoembolization; Liver metastases; Uveal melanoma

Indexed keywords

EMBOLIZATION; LIVER METASTASIS; LIVER VOLUME; MEDIAN SURVIVAL; PARTIAL RESPONSE; TRANSARTERIAL CHEMOEMBOLIZATION; TUMOR EXTENSION; TUMOR PROGRESSIONS; TUMOR RESPONSE; UVEAL MELANOMA;

CHEMOTHERAPY; DERMATOLOGY; LIVER; ONCOLOGY; TUMORS;

PATHOLOGY;

CARBOPLATIN; CISPLATIN; MORPHINE;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; HYDRATION; LIVER ANGIOGRAPHY; LIVER METASTASIS; LIVER SIZE; MALE; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL TIME; TUMOR GROWTH; TUMOR VOLUME; UVEA MELANOMA; VOMITING;

EMBOLIZATION, THERAPEUTIC; FEMALE; HEMOSTATICS; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; PILOT PROJECTS; POLYVINYL ALCOHOL; TREATMENT OUTCOME; UVEAL NEOPLASMS;

EID: 77952879603     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.03.064     Document Type: Article

References (29)

1. Wöll E., Bedikian A., and Legha S.S. Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res 9 (1999) 575-581
2. Bedikian A.Y., Kantarjian H., and Young S.E. Prognosis in metastatic chorioidal melanoma. South Med J 74 (1981) 574-577
3. Jensen O.A. Malignant melanomas of the human uvea: twenty-five-year follow-up of cases in Denmark, 1943-1952. Acta Ophthalmol 60 (1982) 61-182
4. Jäckel A., Bock M., Deichmann M., Waldmann V., and Näher H. Therapie des metastasierten malignen Uveamelanoms. Hautarzt 52 (2001) 98-103
5. Seddon J.M., Albert D.M., Lavin P.T., and Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 101 (1983) 1894-1899
6. Gradoudas E.S., Egan K.M., and Seddon J.M. Survival of patients with metastases from uveal melanoma. Ophthalmology 98 (1991) 383-390
7. Rajpal S., Moore S., and Karakousis C.P. Survival in metastatic ocular melanoma. Cancer 52 (1983) 334-336
8. Kath R., Hayungs J., Bornfeld N., Sauerwein W., Hoffken K., and Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer 72 (1983) 2219-2232
9. Albert D.M., Niffenegger A.S., and Willson J.K.V. Treatment of metastatic uveal melanoma: review and recommendations. Surv Ophthalmol 36 (1992) 429-438
10. Pyrhonen S., Hahka-Kemppinen M., Muhonen T., Nikkanen V., Eskelin S., and Summanen P. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbacine (BOLD), and human leucocyte interferon for metastatic uveal melanoma. Cancer 95 (2002) 2366-2372
11. Nathan F.E., Berd D., Sato T., et al. BOLD + interferon in treatment of metastatic uveal melanoma: first report of active systemic therapy. J Exp Clin Cancer Res 16 (1997) 201-208
12. Kivela T., Suciu S., Hanssou J., Kruit W.H., Vouristo M.S., and Kloke O. Bleomycin, vincristine, lomustine,and dacarbacine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma. Eur J Cancer 39 (2003) 1115-1120
13. Sharma K.V., Gould J.E., Harbour J.W., et al. Hepatic arterial chemoembolization for management of metastatic melanoma. Am J Roentgenol 190 (2008) 99-104
14. Patel K., Sullivan K., Berd D., et al. Chemoembolization of hepatic the artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Res 15 (2005) 297-304
15. Mavligit G.M., Charnsangavej C., Carrasco H., Patt Y.Z., Benjamin R.S., and Wallace S. Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatine and polyvinyl sponge. JAMA 260 (1988) 974-976
16. Bedikian A.Y., Legha S.S., Mavligit G., et al. Treatment of uveal melanoma metastatic to the liver. Cancer 76 (1995) 1665-1670
17. Cantore M., Fiorentini G., Aitini E., et al. Intra-arterial hepatic carboplatin-based chemotherpy for ocular melanoma metastatic to the liver. Report of a phase II study. Tumori 80 (1994) 37-39
18. Leyvraz S., Spataro V., Bauer J., et al. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 15 (1997) 2589-2595
19. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., and Rubinstein L. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
20. Feun L.G., Reddy K.R., Yrizarry J.M., et al. A phase I study of chemoembolization with cisplatine and lipiodol for primary and metastatic liver cancer. Am J Clin Oncol 7/5 (1994) 405-410
21. Sato T., Nathan F.E., Berd D., Sullivan K., and Mastrangelo M.J. Lack of effect from chemoembolization for liver metastasis from uveal melanoma (abstract). Proc Am Soc Clin Oncol 14 (1995) 415
22. Becker J.C., Terheyden P., Kämpgen E., et al. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon a, and interleukin 2. British J Cancer 87 (2002) 840-845
23. Egerer G., Lehnert T., Max R., Naeher H., Keilholz U., and Ho A.D. Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients. Int J Clin Oncol 6 (2002) 25-28
24. Noter S.L., Rothbarth J., Pijl M.E., et al. Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver. Melanoma Res 14 (2004) 67-72
25. Emsinger W.D. Intraarterial therapy. In: Perry M.C. (Ed). The chemotherapy source book. 3rd edn (2001), Lippincott Wiliams & Wilkins, Philadelphia 253-269
26. Macher E. Das maligne Melanom als Krebsmodell. Der Hautarzt 38 (1987) 489-494
27. Rose D.M., Essner R., Hughes T.M., et al. Surgical resection for metastatic melanoma to the liver: The John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 136 (2001) 950-955
28. Alexander H.R., Libutti S.K., Pingpank J.F., et al. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to the liver. Clin Cancer Res 9 17 (2003) 6343-6349
29. Vogl T., Eichler K., Zangos S., et al. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival. J Cancer Res Clin Oncol 133 (2007) 177-184